Physician profile
Peter T Simonson
NPI 1811973258
$2,972.49
in general payments reported to CMS, 2019-2025
27 companies · $62.13 in 2025
The $62.13 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,171 · 2020: $225 · 2021: $703 · 2022: $247 · 2023: $251 · 2024: $314 · 2025: $62.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $552 · Education: $74.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $552.06 |
| Education | $74.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $633.49 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Celularity INC. | $600.00 | 2019-2021 | |
| Therapeuticsmd, INC. | $295.70 | 2019-2022 | |
| Pfizer INC. | $245.99 | 2019-2023 | |
| Exeltis, USA INC. | $216.07 | 2019-2025 | Slynd |
| Astellas Pharma US INC | $194.85 | 2024-2025 | Veozah |
| Roche Diagnostics Corporation | $97.70 | 2019-2020 | |
| Duchesnay USA Incorporated | $92.87 | 2019 | |
| Allergan, INC. | $90.20 | 2019-2020 | |
| Avion Pharmaceuticals | $72.38 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $44.11 | 2023-2024 | Myfembree |
| Hologic Sales and Service, LLC | $42.71 | 2019 | |
| Shield Therapeutics INC | $41.37 | 2024 | |
| Millicent US INC | $35.49 | 2019 | |
| Myovant Sciences INC. | $32.82 | 2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $32.54 | 2024 | Truclear |
| Agile Therapeutics, INC. | $24.51 | 2022 | |
| Mycovia Pharmaceuticals, INC. | $23.13 | 2023 | Vivjoa |
| Coopersurgical, INC. | $22.81 | 2021 | |
| Organon LLC | $21.69 | 2022 | |
| Evofem Biosciences, INC. | $20.42 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.42 | 2019 | |
| Exact Sciences Corporation | $16.70 | 2025 | Cologuard Collection Kit |
| Biohaven Pharmaceuticals, INC. | $16.06 | 2021 | |
| Amag Pharmaceuticals, INC. | $14.95 | 2019 | |
| Mayne Pharma Commercial LLC | $12.89 | 2021 | |
| Minerva Surgical, INC | $12.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Simonson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.